Which components are contained in Ultibro Breezhaler?

Study for the Foundation Year Pharmacy – Clinical Practice Test. Prepare with detailed questions, step-by-step explanations, and test format insights. Enhance your readiness and confidence!

Multiple Choice

Which components are contained in Ultibro Breezhaler?

Explanation:
Ultibro Breezhaler is a fixed-dose inhaler that combines two long-acting bronchodilators: indacaterol and glycopyrronium. Indacaterol is a long-acting beta-2 agonist that relaxes airway smooth muscle by stimulating beta receptors, while glycopyrronium is a long-acting muscarinic antagonist that blocks acetylcholine-mediated bronchoconstriction. Using these two agents together provides ongoing bronchodilation through complementary mechanisms, helping to improve symptoms and reduce COPD exacerbations. Other options mix short-acting agents or include an inhaled corticosteroid, or pair different long-acting agents not specific to this product, so the correct components are indacaterol and glycopyrronium.

Ultibro Breezhaler is a fixed-dose inhaler that combines two long-acting bronchodilators: indacaterol and glycopyrronium. Indacaterol is a long-acting beta-2 agonist that relaxes airway smooth muscle by stimulating beta receptors, while glycopyrronium is a long-acting muscarinic antagonist that blocks acetylcholine-mediated bronchoconstriction. Using these two agents together provides ongoing bronchodilation through complementary mechanisms, helping to improve symptoms and reduce COPD exacerbations. Other options mix short-acting agents or include an inhaled corticosteroid, or pair different long-acting agents not specific to this product, so the correct components are indacaterol and glycopyrronium.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy